Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $3.70, but opened at $3.92. Raia Drogasil shares last traded at $3.92, with a volume of 347 shares traded.
Raia Drogasil Stock Up 0.5%
The firm has a 50 day moving average of $3.59 and a two-hundred day moving average of $4.07.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting analysts’ consensus estimates of $0.05. The firm had revenue of $2.17 billion for the quarter, compared to analysts’ expectations of $2.32 billion. As a group, equities analysts predict that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Recommended Stories
- Five stocks we like better than Raia Drogasil
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
